Tech Company Financing Transactions
Shift Bioscience Funding Round
Shift Bioscience closed a $16 million Seed venture capital round on 10/15/2024. Investors included BGF Ventures, F-Prime Capital and private investors.
Transaction Overview
Company Name
Announced On
10/15/2024
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds for the continued development of its artificial intelligence (AI) cell simulation platform, for the identification of genes that can safely rejuvenate cells to combat the effects of age-related illnesses.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
The Gurdon Institute, Tennis Court Road
Cambridge, CB2 1QN
UK
Cambridge, CB2 1QN
UK
Phone
Undisclosed
Website
Email Address
Overview
Shift's platform has discovered 6 gene-based interventions that reverse epigenetic age without inducing stem cell colonies, including a single-gene intervention. We are continuously improving our cell aging clocks, cell simulations and active learning cycles to accelerate future discovery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
David Prior
Chief Executive Officer
Daniel Ives
Browse more venture capital transactions:
Prev: 10/15/2024: Healthie venture capital transaction
Next: 10/15/2024: Path Robotics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs